Improvement of chloride transport defect by Gonadotropin-Releasing Hormone (GnRH) in cystic fibrosis epithelial cells

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Benz, Nathalie ^a,b   Le Hir, Sophie ^a,c   Norez, Caroline ^d   Kerbiriou, Mathieu ^a,e   Calvez, Marie Laure ^a,e   Becq, Frédéric ^d   Trouvé, Pascal ^a   Férec, Claude ^a,c,e,f  

^a French Blood Agency   (France)

^b Association Gaetan Saleun   (France)

^c CHU MORVAN   (France)

^d UNIVERSITÉ DE POITIERS   (France)

^e FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^f ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GONADORELIN; GONADORELIN RECEPTOR; LIPOCORTIN 5; CFTR PROTEIN, HUMAN; CHLORIDE; GNRHR PROTEIN, HUMAN;

ARTICLE; CELL MEMBRANE; CELL SURFACE; CHLORIDE CHANNELOPATHY; CHLORIDE TRANSPORT; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG MECHANISM; ENDOPLASMIC RETICULUM; EPITHELIUM CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STABILITY; CELL CULTURE; DRUG EFFECTS; GENE EXPRESSION; GENETICS; METABOLISM; MUTATION; PATHOLOGY; TRANSPORT AT THE CELLULAR LEVEL;

ANNEXIN A5; BIOLOGICAL TRANSPORT; CELLS, CULTURED; CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; EPITHELIAL CELLS; GENE EXPRESSION; GONADOTROPIN-RELEASING HORMONE; HUMANS; MUTATION; RECEPTORS, LHRH;

EID: 84896124153     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088964     Document Type: Article

References (55)

1. Riordan JR, Rommens JM, Kerem B, Alon N, Rozmahel R et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245: 1066-1073. (Pubitemid 19231814)
2. Bear CE, Li CH, Kartner N, Bridges RJ, Jensen TJ et al. (1992) Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell: 68: 809-818.
3. Amaral MD (2004) Cftr and chaperones: Processing and degradation. J MolNeurosci 23: 41-48.
4. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW et al. (1990) Defective intracellular transport and processing of cftr is the molecular basis of most cystic fibrosis. Cell 63: 827-834. (Pubitemid 120035055)
5. Lukacs GL, Mohamed A, Kartner N, Chang XB, Riordan JR et al. (1994) Conformational maturation of cftr but not its mutant counterpart (delta f508) occurs in the endoplasmic reticulum and requires atp. EMBO J 13: 6076-6086.
6. Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL et al. (1995) Multiple proteolytic systems, including the proteasome, contribute to cftr processing. Cell 83: 129-135.
7. Ward CL, Omura S, Kopito RR (1995) Degradation of cftr by the ubiquitin-proteasome pathway. Cell 83: 121-127.
8. - channel by ATP-driven nucleotide-binding domain dimerisation. J Physiol 587: 2151-2161.
9. Zielenski J, Tsui LC (1995) Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet 29: 777-807. (Pubitemid 26005359)
10. Cheng SH, Gregory RJ, Marshall J, Paul S, Souza DW et al. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell 63: 827-834. (Pubitemid 120035055)
11. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE et al. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358: 761-764.
12. Sato S, Ward CL, Krouse ME, Wine JJ, Kopito RR (1996) Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation. J Biol Chem 271: 635-638. (Pubitemid 26034907)
13. Welsh MJ, Denning GM, Ostedgaard LS, Anderson MP (1993) Dysfunction of CFTR bearing the delta F508 mutation. J Cell Sci. Suppl. 17: 235-239. (Pubitemid 24041304)
14. Dalemans W, Barbry P, Champigny G, Jallat S, Dott K et al. (1991) Altered chloride ion channel kinetics associated with the ΔF508 cystic fibrosis mutation. Nature 354: 526-528. (Pubitemid 21896832)
15. Ostedgaard LS, Rogers CS, Dong Q, Randak CO, Vermeer DW et al. (2007) Processing and function of CFTR-DF508 are species-dependent. Proc Natl Acad Sci USA 104: 15370-15375. (Pubitemid 47502924)
16. Miki H, Zhou Z, Li M, Hwang TC, Bompadre SG (2010) Potentiation of disease-associated cystic fibrosis transmembrane conductance regulator mutants by hydrolyzable ATP analogs. J Biol Chem 285: 19967-19975.
17. Lukacs GL, Chang XB, Bear C, Kartner N, Mohamed A et al. (1993) The delta F508 mutation decreases the stability of cystic fibrosis transmembrane conductance regulator in the plasma membrane. Determination of functional half-lives on transfected cells. J. Biol. Chem. 268: 21592-21598. (Pubitemid 23320650)
18. Hwang TC, Wang F, Yang IC, Reenstra WW (1997) Genistein potentiates wild-type and delta F508-CFTR channel activity. Am. J. Physiol. 273: C988-C998. (Pubitemid 27422179)
19. Cai Z, Sheppard DN (2002) Phloxine B interacts with the cystic fibrosis transmembrane conductance regulator at multiple sites to modulate channel activity. J. Biol. Chem. 277: 19546-19553. (Pubitemid 34967467)
20. Vergani P, Lockless SW, Nairn AC, Gadsby DC (2005) CFTR channel opening by ATP-driven tight dimerization of its nucleotide-binding domains. Nature 433: 876-880. (Pubitemid 40314897)
21. Rubenstein RC, Egan ME, Zeitlin PL (1997) In vitro pharmacologic restoration of CFTR-mediated chloride transport with sodium 4-phenylbutyrate in cystic fibrosis epithelial cells containing delta F508-CFTR. J. Clin. Invest. 100: 2457-2465. (Pubitemid 27514885)
22. Brown CR, Hong-Brown LQ, Biwersi J, Verkman AS, Welch WJ (1996) Chemical chaperones correct the mutant phenotype of the delta F508 cystic fibrosis transmembrane conductance regulator protein. Cell Stress Chaperones 1: 117-125. (Pubitemid 126670773)
23. Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE et al. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358: 761-764.
24. Norez C, Noel S, Wilke M, Bijvelds M, Jorna H et al. (2006) Rescue of functional delF508-CFTR channels in cystic fibrosis epithelial cells by the alpha-glucosidase inhibitor miglustat. FEBS Lett. 580: 2081-2086.
25. Wang Y, Bartlett MC, Loo TW, Clarke DM (2006) Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones. Mol. Pharmacol. 70(1): 297-302.
26. Wang Y, Loo TW, Bartlett MC, Clarke DM (2007) Correctors promote maturation of cystic fibrosis transmembrane conductance regulator (CFTR)-processing mutants by binding to the protein. J. Biol. Chem. 282: 33247-33251. (Pubitemid 350159496)
27. Becq F, Mettey Y, Gray MA, Galietta LJ, Dormer RL et al. (1999) Development of substituted Benzo[c]quinolizinium compounds as novel activators of the cystic fibrosis chloride channel. J. Biol. Chem. 274: 27415-27425.
28. Trouvé P, LeDrévo MA, Kerbiriou M, Fichou Y, Gillet D et al. (2007) Annexin V is directly involved in cystic fibrosis transmembrane conductance regulator's chloride channel function. Biochim Biophys Acta. 1772: 1121-1133. (Pubitemid 350184270)
29. Le Drévo MA, Benz N, Kerbiriou M, Gioux M, Pennec JP et al. (2008) Annexin A5 increases the cell surface expression and the chloride channel function of the ΔF508-Cystic Fibrosis Transmembrane Regulator. Biochim Biophys Acta 1782: 605-614.
30. Kawaminami M, Etoh S, Miyaoka H, Sakai M, Nishida M et al. (2002) Annexin 5 messenger ribonucleic acid expression in pituitary gonadotropes is induced by gonadotropin-releasing hormone (GnRH) and modulates GnRH stimulation of gonadotropin release. Neuroendocrinology 75(1): 2-11. (Pubitemid 34124212)
31. Yao B, Kawaminami M (2008) Stimulation of annexin A5 expression by gonadotropin releasing hormone (GnRH) in the Leydig cells of rats. J Reprod Dev 54(4): 259-264.
32. Kawaminami M, Uematsu N, Funahashi K, Kokubun R, Kurusu S (2008) Gonadotropin releasing hormone (GnRH) enhances annexin A5 mRNA expression through mitogen activated protein kinase (MAPK) in LbetaT2 pituitary gonadotrope cells. Endocr J. 55(6): 1005-1014.
33. Cozens AL, Yessi MJ, Kunzelmann K, Ohrui T, Chin L et al. (1994) CFTR expression and Chloride secretion in polarized immortal human bronchial epithelial cells. Am J Respir Cell Mol Biol 10: 38-47.
34. Bruscia E, Sangiuolo F, Sinibaldi P, Goncz KK, Novelli G et al. (2002) Isolation of CF cell lines corrected at DeltaF508-CFTR locus by SFHR-mediated targeting. Gene Ther. 9: 683-685. (Pubitemid 34591465)
35. Illek B, Maurisse R, Wahler L, Kunzelmann K, Fischer H et al. (2008) Cl transport in complemented CF bronchial epithelial cells correlates with CFTR mRNA expression levels. Cell. Physiol. Biochem. 22: 57-68.
36. Bebok Z, Collawn JF, Wakefield J, Parker W, Li Y et al. (2005) Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers. J. Physiol. 569: 601-615. (Pubitemid 41830125)
37. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275.
38. Norez C, Antigny F, Becq F, Vandebrouck C (2006) Maintaining Low Ca2+ Level in the Endoplasmic Reticulum Restores Abnormal Endogenous F508del-CFTR Trafficking in Airway Epithelial Cells. Traffic 7: 562-573. (Pubitemid 44026754)
39. Farre C, Stoelzle S, Haarmann C, George M, Brüggemann A et al. (2007) Automated ion channel screening: patch clamping made easy. Expert Opin Ther Targets 11(4): 557-65. (Pubitemid 46487602)
40. McKone EF, Emerson SS, Edwards KL, Aitken ML (2003) Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 361: 1671-1676. (Pubitemid 36577438)
41. Zhang L, Button B, Gabriel SE, Burkett S, Yan Y et al. (2009) CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium. PLoS Biol. 7 e1000155.
42. Gerke V, Moss SE (2002) Annexins: from structure to function. Physiol Rev 82: 331-371. (Pubitemid 34654456)
43. Crompton MR, Moss SE, Crumpton MJ (1988) Diversity in the lipocortin/calpactin family. Cell 55: 1-3.
44. Moss SE, Morgan RO (2004) The annexins. Genome Biol 5: 219.
45. Rojas E, Pollard HB, Haigler HT, Parra C, Burns AL (1990) Calcium-activated endonexin II forms calcium channels across acidic phospholipid bilayer membranes. J Biol Chem 265: 21207-21215. (Pubitemid 120014141)
46. Faria D, Dahimène S, Alessio L, Scott-Ward T, Schreiber R et al. (2011) Effect of Annexin A5 on CFTR: regulated traffic or scaffolding? Mol Membr Biol. 28(1): 14-29.
47. Borthwick LA, Botha P, Verdon B, Brodlie MJ, Gardner A et al. (2011) Is CFTR-delF508 really absent from the apical membrane of the airway epithelium? PLoS One 6(8): e23226.
48. Kakar SS, Jennes L (1995) Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues. Cancer Lett. 98(1): 57-62.
49. Tieva A, Stattin P, Wikström P, Bergh A, Damber JE (2001) Gonadotropin-releasing hormone receptor expression in the human prostate. Prostate 47(4): 276-284. (Pubitemid 32521747)
50. Koushik K, Bandi N, Sundaram S, Kompella UB (2004) Evidence for LHRH-Receptor Expression in Human Airway Epithelial (Calu-3) Cells and Its Role in the Transport of a LHRH Agonist. Pharmaceutical Research 21(6): 1034-1046. (Pubitemid 38870155)
51. Reutelingsperger CP, van Heerde W, Hauptmann R, Maassen C, van Gool RG et al. (1994) Differential tissue expression of Annexin VIII in human. FEBS Lett. 349(1): 120-124. (Pubitemid 24230234)
52. Kawaminami M, Tsuchiyama Y, Saito S, Katayama M, Kurusu S et al. (2002) Gonadotropin-releasing hormone stimulates annexin 5 messenger ribonucleic acid expression in the anterior pituitary cells. Biochem Biophys Res Commun. 291(4): 915-920. (Pubitemid 34694362)
53. Alzamora R, King JD Jr, Hallows KR (2011) CFTR regulation by phosphorylation. Methods Mol Biol. 741: 471-488.
54. Baudouin-Legros M, Hinzpeter A, Jaulmes A, Brouillard F, Costes B et al. (2005) Cell-specific posttranscriptional regulation of CFTR gene expression via influence of MAPK cascades on 3′UTR part of transcripts. Am J Physiol Cell Physiol 289(5): C1240-C1250. (Pubitemid 41456840)
55. Rowe SM. Verkman AS (2013) Cystic fibrosis transmembrane regulator correctors and potentiators. Cold Spring Harb Perspect Med. 3(7): a009761.